Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Cloning and characterization of serpin from red king crab Paralithodes camtschaticus.

Kostin NN, Bobik TV, Shurdova EM, Ziganshin RH, Surina EA, Shagin DA, Shagina IA, Knorre VD, Isaev VA, Rudenskaya GN, Gabibov AG, Smirnov IV.

Fish Shellfish Immunol. 2018 Jul 10;81:99-107. doi: 10.1016/j.fsi.2018.07.014. [Epub ahead of print]

PMID:
30006043
2.

Generation of Highly Specific Proteolytic Biocatalysts by Screening Technologies.

Bobik TV, Kostin NN, Knorre VD, Gabibov AG, Smirnov IV.

Bull Exp Biol Med. 2018 Jul 12. doi: 10.1007/s10517-018-4179-6. [Epub ahead of print]

PMID:
30003414
3.

Genetically encoded calcium indicator with NTnC-like design and enhanced fluorescence contrast and kinetics.

Doronin DA, Barykina NV, Subach OM, Sotskov VP, Plusnin VV, Ivleva OA, Isaakova EA, Varizhuk AM, Pozmogova GE, Malyshev AY, Smirnov IV, Piatkevich KD, Anokhin KV, Enikolopov GN, Subach FV.

BMC Biotechnol. 2018 Feb 13;18(1):10. doi: 10.1186/s12896-018-0417-2.

4.

[Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates].

Mokrushina YA, Pipiya SO, Stepanova AV, Shamborant OG, Knorre VD, Smirnov IV, Gabibov AG, Vorobiev II.

Mol Biol (Mosk). 2017 Nov-Dec;51(6):958-968. doi: 10.7868/S0026898417060088. Russian.

5.

Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.

Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, Nelson SJ, Woehrer A, Phillips JJ, Solomon DA, Costello JF.

Neuro Oncol. 2018 Apr 9;20(5):632-641. doi: 10.1093/neuonc/nox205.

PMID:
29077933
6.

Comprehensive Analysis of Hypermutation in Human Cancer.

Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A.

Cell. 2017 Nov 16;171(5):1042-1056.e10. doi: 10.1016/j.cell.2017.09.048. Epub 2017 Oct 19.

7.

Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.

Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, Cairncross JG, Perry A, Nelson SJ, Chang SM, Bollen AW, Molinaro AM, Bengtsson H, Olshen AB, Weiss S, Phillips JJ, Luchman HA, Costello JF.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10743-10748. doi: 10.1073/pnas.1708914114. Epub 2017 Sep 15.

8.

Evolution of catalytic centers of antibodies by virtual screening of broad repertoire of mutants using supercomputer.

Golovin AV, Smirnov IV, Stepanova AV, Zalevskiy AO, Zlobin AS, Ponomarenko NA, Belogurov AA, Knorre VD, Hurs EN, Chatziefthimiou SD, Wilmanns M, Blackburn GM, Khomutov RM, Gabibov AG.

Dokl Biochem Biophys. 2017 Jul;475(1):245-249. doi: 10.1134/S1607672917040019. Epub 2017 Sep 2.

PMID:
28864894
9.

Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate Poisoning.

Terekhov SS, Palikov VA, Palikova YA, Dyachenko IA, Shamborant OG, Smirnov IV, Masson P, Gabibov AG.

Bull Exp Biol Med. 2017 Aug;163(4):430-435. doi: 10.1007/s10517-017-3821-z. Epub 2017 Aug 29.

PMID:
28853097
10.

Evolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis.

Zakharova MY, Kuznetsova AA, Kaliberda EN, Dronina MA, Kolesnikov AV, Kozyr AV, Smirnov IV, Rumsh LD, Fedorova OS, Knorre DG, Gabibov AG, Kuznetsov NA.

Biochimie. 2017 Nov;142:125-134. doi: 10.1016/j.biochi.2017.08.014. Epub 2017 Aug 24.

PMID:
28843613
11.

Green fluorescent genetically encoded calcium indicator based on calmodulin/M13-peptide from fungi.

Barykina NV, Subach OM, Piatkevich KD, Jung EE, Malyshev AY, Smirnov IV, Bogorodskiy AO, Borshchevskiy VI, Varizhuk AM, Pozmogova GE, Boyden ES, Anokhin KV, Enikolopov GN, Subach FV.

PLoS One. 2017 Aug 24;12(8):e0183757. doi: 10.1371/journal.pone.0183757. eCollection 2017.

12.

Genetic Engineering of Native Chain Combinations of B-Cell Repertoires on the Surface of Methylotrophic Yeasts Pichia pastoris.

Bobik TV, Shurdova EM, Smirnov IV, Ponomarenko NA, Khurs EN, Knorre VD, Gabibov AG.

Bull Exp Biol Med. 2017 Jun;163(2):263-267. doi: 10.1007/s10517-017-3780-4. Epub 2017 Jul 18.

PMID:
28726211
13.

Preparation of Recombinant Serpin from Red King Crab Paralithodes сamtschaticus for Biomedical Research Purposes.

Kostin NN, Ponomarenko NA, Isaev VA, Rudenskaya GN, Bobik TV, Gabibov AG, Smirnov IV.

Bull Exp Biol Med. 2017 Jun;163(2):210-213. doi: 10.1007/s10517-017-3768-0. Epub 2017 Jul 18.

PMID:
28726206
14.

A Study of the Protective Properties of an Antibody-Based Antidote Metabolizing Organophosphorus Pesticide Paraoxon.

Mokrushina YA, Stepanova AV, Palikov VA, Stepanov AV, Belous GI, Dyachenko IA, Knorre VD, Smirnov IV, Gabibov AG.

Bull Exp Biol Med. 2017 Jun;163(2):218-221. doi: 10.1007/s10517-017-3770-6. Epub 2017 Jul 18.

PMID:
28726199
15.

Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.

Zhang C, de Smith AJ, Smirnov IV, Wiencke JK, Wiemels JL, Witte JS, Walsh KM.

J Neurooncol. 2017 Nov;135(2):237-244. doi: 10.1007/s11060-017-2569-7. Epub 2017 Jul 18.

PMID:
28721485
16.

Design of Chemical Conjugate for Targeted Therapy of Multiple Sclerosis Based of Constant Fragment of Human Antibody Heavy Chain and Peptoid Analog of Autoantigen MOG35-55.

Lomakin YA, Stepanov AV, Balabashin DS, Ponomarenko NA, Smirnov IV, Belogurov AA Jr.

Bull Exp Biol Med. 2017 Apr;162(6):777-780. doi: 10.1007/s10517-017-3711-4. Epub 2017 Apr 21.

PMID:
28429225
17.

Structural modification of titanium surface by octacalcium phosphate via Pulsed Laser Deposition and chemical treatment.

Smirnov IV, Rau JV, Fosca M, De Bonis A, Latini A, Teghil R, Kalita VI, Fedotov AY, Gudkov SV, Baranchikov AE, Komlev VS.

Bioact Mater. 2017 Mar 22;2(2):101-107. doi: 10.1016/j.bioactmat.2017.03.002. eCollection 2017 Jun.

18.

Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity.

Terekhov SS, Smirnov IV, Stepanova AV, Bobik TV, Mokrushina YA, Ponomarenko NA, Belogurov AA Jr, Rubtsova MP, Kartseva OV, Gomzikova MO, Moskovtsev AA, Bukatin AS, Dubina MV, Kostryukova ES, Babenko VV, Vakhitova MT, Manolov AI, Malakhova MV, Kornienko MA, Tyakht AV, Vanyushkina AA, Ilina EN, Masson P, Gabibov AG, Altman S.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2550-2555. doi: 10.1073/pnas.1621226114. Epub 2017 Feb 15.

19.

Robotic QM/MM-driven maturation of antibody combining sites.

Smirnov IV, Golovin AV, Chatziefthimiou SD, Stepanova AV, Peng Y, Zolotareva OI, Belogurov AA Jr, Kurkova IN, Ponomarenko NA, Wilmanns M, Blackburn GM, Gabibov AG, Lerner RA.

Sci Adv. 2016 Oct 19;2(10):e1501695. eCollection 2016 Oct.

20.

A new design for a green calcium indicator with a smaller size and a reduced number of calcium-binding sites.

Barykina NV, Subach OM, Doronin DA, Sotskov VP, Roshchina MA, Kunitsyna TA, Malyshev AY, Smirnov IV, Azieva AM, Sokolov IS, Piatkevich KD, Burtsev MS, Varizhuk AM, Pozmogova GE, Anokhin KV, Subach FV, Enikolopov GN.

Sci Rep. 2016 Sep 28;6:34447. doi: 10.1038/srep34447.

21.

[Technologies for Complex Intelligent Clinical Data Analysis].

Baranov AA, Namazova-Baranova LS, Smirnov IV, Devyatkin DA, Shelmanov AO, Vishneva EA, Antonova EV, Smirnov VI.

Vestn Ross Akad Med Nauk. 2016;(2):160-71. Russian.

PMID:
27522718
22.

[STUDYING GASTRIC ULCERATION EFFECT OF A NEW DRUG INTENDED FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES OF KIDNEYS AND URINARY TRACT.]

Murashko TO, Smirnov IV, Ivanov AA, Postnikov PS, Nemtsev AO, Bondarev AA, Udut VV, Prisukhin AN, Kornaukhov AN, Sergeev TS.

Eksp Klin Farmakol. 2016 Aug;79(5):26-28. Russian.

PMID:
29782776
23.

New Genetic Constructs for Generation of Stable Therapeutic Antibodies to Organophosphorus Toxins in Methylotrophic Yeasts Pichia Pastoris.

Mokrushina YA, Stepanova AV, Bobik TV, Smirnov IV, Gabibov AG.

Bull Exp Biol Med. 2016 May;161(1):83-7. doi: 10.1007/s10517-016-3351-0. Epub 2016 Jun 6.

PMID:
27270933
24.

[Expression Of DNA-Encoded Antidote to Organophosphorus Toxins in the Methylotrophic Yeast Pichia Pastoris].

Terekhov SS, Bobik TV, Mokrushina YA, Stepanova AV, Aleksandrova NM, Smirnov IV, Belogurov AA, Ponomarenko NA, Gabibov AG.

Prikl Biokhim Mikrobiol. 2016 Mar-Apr;52(2):184-92. Russian.

PMID:
27266247
25.

Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.

Walsh KM, Whitehead TP, de Smith AJ, Smirnov IV, Park M, Endicott AA, Francis SS, Codd V; ENGAGE Consortium Telomere Group, Samani NJ, Metayer C, Wiemels JL.

Carcinogenesis. 2016 Jun;37(6):576-582. doi: 10.1093/carcin/bgw037. Epub 2016 Apr 1.

26.

Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia.

Ojha J, Codd V, Nelson CP, Samani NJ, Smirnov IV, Madsen NR, Hansen HM, de Smith AJ, Bracci PM, Wiencke JK, Wrensch MR, Wiemels JL, Walsh KM; ENGAGE Consortium Telomere Group.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1043-9. doi: 10.1158/1055-9965.EPI-15-1329. Epub 2016 May 13.

27.

[DIURETIC ACTIVITY OF 4-O-CARBOXYPHENYL-D-GLUCOPYRANOSIDE SODIUM SALT ADMINISTERED VIA DIFFERENT ROUTES].

Smirnov IV, Murashko TO, Ivanov AA, Nemtsev AO, Postnikov PS, Bondarev AA, Udut VV.

Eksp Klin Farmakol. 2016;79(1):20-2. Russian.

PMID:
27159953
28.

Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers.

Terekhov SS, Smirnov IV, Shamborant OG, Bobik TV, Ilyushin DG, Murashev AN, Dyachenko IA, Palikov VA, Knorre VD, Belogurov AA, Ponomarenko NA, Kuzina ES, Genkin DD, Masson P, Gabibov AG.

Acta Naturae. 2015 Oct-Dec;7(4):136-41.

29.

Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.

Walsh KM, Codd V, Rice T, Nelson CP, Smirnov IV, McCoy LS, Hansen HM, Elhauge E, Ojha J, Francis SS, Madsen NR, Bracci PM, Pico AR, Molinaro AM, Tihan T, Berger MS, Chang SM, Prados MD, Jenkins RB, Wiemels JL; ENGAGE Consortium Telomere Group, Samani NJ, Wiencke JK, Wrensch MR.

Oncotarget. 2015 Dec 15;6(40):42468-77. doi: 10.18632/oncotarget.6468.

30.

[PRODUCTION AND CHARACTERIZATION OF THE PANEL OF MONOCLONAL ANTIBODIES AGAINST HUMAN ENDOGLIN].

Smirnov IV, Gryazeva IV, Samoilovich MP, Terekhina LA, Pinevich AA, Krylova AA, Krutetskaia IY, Nikolsky NN, Klimovich VB.

Tsitologiia. 2015;57(7):499-508. Russian.

PMID:
26591062
31.

A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.

Walsh KM, de Smith AJ, Hansen HM, Smirnov IV, Gonseth S, Endicott AA, Xiao J, Rice T, Fu CH, McCoy LS, Lachance DH, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR, Ma X, Metayer C, Wiemels JL.

Cancer Res. 2015 Nov 15;75(22):4884-94. doi: 10.1158/0008-5472.CAN-15-1105. Epub 2015 Nov 2.

32.

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.

Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJA, Smirnov IV, Reis GF, Phillips JJ, Barnes MJ, Idbaih A, Alentorn A, Kloezeman JJ, Lamfers MLM, Bollen AW, Taylor BS, Molinaro AM, Olshen AB, Chang SM, Song JS, Costello JF.

Cancer Cell. 2015 Sep 14;28(3):307-317. doi: 10.1016/j.ccell.2015.07.012.

33.

3D Printing of Octacalcium Phosphate Bone Substitutes.

Komlev VS, Popov VK, Mironov AV, Fedotov AY, Teterina AY, Smirnov IV, Bozo IY, Rybko VA, Deev RV.

Front Bioeng Biotechnol. 2015 Jun 8;3:81. doi: 10.3389/fbioe.2015.00081. eCollection 2015.

34.

Chemical Polysialylation of Recombinant Human Proteins.

Smirnov IV, Vorobiev II, Belogurov AA, Genkin DD, Deyev SM, Gabibov AG.

Methods Mol Biol. 2015;1321:389-404. doi: 10.1007/978-1-4939-2760-9_26.

PMID:
26082236
35.

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O'Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB.

N Engl J Med. 2015 Jun 25;372(26):2499-508. doi: 10.1056/NEJMoa1407279. Epub 2015 Jun 10.

36.

[Risk management of a patient on the basis of remote health monitoring: current situation and prospects].

Namazova-Baranova LS, Suvorov RE, Smirnov IV, Molodchenkov AI, Antonova EV, Vishneva EA, Smirnov VI.

Vestn Ross Akad Med Nauk. 2015;(1):82-9. Review. Russian.

PMID:
26027275
37.

Excessive Labeling Technique Provides a Highly Sensitive Fluorescent Probe for Real-time Monitoring of Biodegradation of Biopolymer Pharmaceuticals in vivo.

Terekhov SS, Smirnov IV, Shamborant OG, Zenkova MA, Chernolovskaya EL, Gladkikh DV, Murashev AN, Dyachenko IA, Knorre VD, Belogurov AA, Ponomarenko NA, Deyev SM, Vlasov VV, Gabibov AG.

Acta Naturae. 2014 Oct;6(4):54-9.

38.

[SEARCHING FOR NEW SYNTHETIC DIURETICS].

Smirnov IV, Murashko TO, Ivanov AA, Nemtsev AO, Bondarev AA, Udut VV.

Eksp Klin Farmakol. 2015;78(12):3-5. Russian.

PMID:
27051919
39.

[Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].

Smirnov IV, Gryazeva IV, Samoilovich MP, Klimovich VB.

Vopr Onkol. 2015;61(6):898-907. Review. Russian.

PMID:
26995976
40.

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, Pico AR, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, O'Neill BP, Sicotte H, Eckel-Passow JE; ENGAGE Consortium Telomere Group, van der Harst P, Wiencke JK, Samani NJ, Jenkins RB, Wrensch MR.

Nat Genet. 2014 Jul;46(7):731-5. doi: 10.1038/ng.3004. Epub 2014 Jun 8.

41.

Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.

Lomakin YA, Zakharova MY, Stepanov AV, Dronina MA, Smirnov IV, Bobik TV, Pyrkov AY, Tikunova NV, Sharanova SN, Boitsov VM, Vyazmin SY, Kabilov MR, Tupikin AE, Krasnov AN, Bykova NA, Medvedeva YA, Fridman MV, Favorov AV, Ponomarenko NA, Dubina MV, Boyko AN, Vlassov VV, Belogurov AA Jr, Gabibov AG.

Mol Immunol. 2014 Dec;62(2):305-14. doi: 10.1016/j.molimm.2014.01.013. Epub 2014 Feb 16.

42.

Immunoproteasome enhances intracellular proteolysis of myelin basic protein.

Kuzina ES, Chernolovskaya EL, Kudriaeva AA, Zenkova MA, Knorre VD, Surina EA, Ponomarenko NA, Bobik TV, Smirnov IV, Bacheva AV, Belogurov AA, Gabibov AG, Vlasov VV.

Dokl Biochem Biophys. 2013 Nov;453:300-3. doi: 10.1134/S1607672913060070. Epub 2014 Jan 3. No abstract available.

PMID:
24385101
43.

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.

Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.

Science. 2014 Jan 10;343(6167):189-193. doi: 10.1126/science.1239947. Epub 2013 Dec 12.

44.
45.

Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children.

Walsh KM, Chokkalingam AP, Hsu LI, Metayer C, de Smith AJ, Jacobs DI, Dahl GV, Loh ML, Smirnov IV, Bartley K, Ma X, Wiencke JK, Barcellos LF, Wiemels JL, Buffler PA.

Leukemia. 2013 Dec;27(12):2416-9. doi: 10.1038/leu.2013.130. Epub 2013 Apr 25. No abstract available.

46.

Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.

Ilyushin DG, Haertley OM, Bobik TV, Shamborant OG, Surina EA, Knorre VD, Masson P, Smirnov IV, Gabibov AG, Ponomarenko NA.

Acta Naturae. 2013 Jan;5(1):73-84.

47.

Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Ilyushin DG, Smirnov IV, Belogurov AA Jr, Dyachenko IA, Zharmukhamedova TIu, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1243-8. doi: 10.1073/pnas.1211118110. Epub 2013 Jan 7.

48.

Creation of catalytic antibodies metabolizing organophosphate compounds.

Kurkova IN, Smirnov IV, Belogurov AA Jr, Ponomarenko NA, Gabibov AG.

Biochemistry (Mosc). 2012 Oct;77(10):1139-46. doi: 10.1134/S0006297912100069. Review.

49.

Liposome-encapsulated peptides protect against experimental allergic encephalitis.

Belogurov AA Jr, Stepanov AV, Smirnov IV, Melamed D, Bacon A, Mamedov AE, Boitsov VM, Sashchenko LP, Ponomarenko NA, Sharanova SN, Boyko AN, Dubina MV, Friboulet A, Genkin DD, Gabibov AG.

FASEB J. 2013 Jan;27(1):222-31. doi: 10.1096/fj.12-213975. Epub 2012 Oct 9.

50.

[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].

Stepanov AV, Belogurov AA, Mamedov AÉ, Melamed D, Smirnov IV, Kuzina ES, Genkin DD, Boĭko AN, Sharanova SN, Bacon A, Ponomarenko NA, Gabibov AG.

Bioorg Khim. 2012 May-Jun;38(3):306-14. Russian.

PMID:
22997702

Supplemental Content

Loading ...
Support Center